20May/13

Life Technologies Announces Regulatory Approval of its 3500 Dx Series Genetic … – DigitalJournal.com (press release)

Life Technologies Announces Regulatory Approval of its 3500 Dx Series Genetic
DigitalJournal.com (press release)
In February 2013, the 3500 Dx/3500xL Dx Genetic Analyzers CS2 Series received U.S. Food and Drug Administration (FDA) 510(k) clearance for use with the company’s SeCore® HLA typing kits. Additional products offered by Life Technologies for the

and more »

20May/13

Increased Mortality Risk, Likelihood Of Hospital Readmission Following Heart … – Big News Network.com

Increased Mortality Risk, Likelihood Of Hospital Readmission Following Heart
Big News Network.com
heart failure patients may have a high risk of death or re-admission for a month or longer after leaving the hospital, researchers said at the American Heart Association’s Quality of Care and Outcomes Scientific Sessions 2013. “The risks of death and